Nephrology Hypertension
Hemodialysis: Acute Complications - Anaphylactic/Anaphylactoid Reactions
- Does this patient have anaphylactic/anaphylactoid reaction?
-
What tests to perform?
- How should patients with anaphylactic/anaphylactoid reactions be managed?
-
What happens to patients with anaphylactic/anaphylactoid reactions?
-
How to utilize team care?
-
Are there clinical practice guidelines to inform decision making?
-
Other considerations
Does this patient have anaphylactic/anaphylactoid reaction?
Symptoms and signs usually develop within first 5 minutes after starting dialysis
Rhinorrhea
Sneezing
Coughing
Lacrimation
Burning or heat throughout body or vascular access site
Flushing
Pruritus
Nausea/vomiting
Abdominal pain
Diarrhea
Agitation
Chest pain or chest discomfort
Dyspnea
Angioedema
Laryngeal edema
Paresthesias involving fingers, toes, lips, or tongue
Hypotension
Sudden cardiac arrest
Causes
Ethylene oxide (ETO) from manufacturer's dialyzer sterilant (dialyzer first-use reaction)
Formaldehyde (germicide) retained in dialyzer following disinfection (dialyzer reuse reaction)
Peracetic acid/hydrogen peroxide (Renalin, germicide) retained in dialyzer following disinfection (dialyzer reuse reaction)
Bradykinin release (observed in patients receiving angiotensin II converting enzyme [ACE] inhibitor) and using either
An AN69 dialyzer
A reused dialyzer (usually with peracetic acid/hydrogen peroxide)
Histamine release following exposure to:
Iron dextran
Desferoxamine (rare)
Heparin (rare)
What tests to perform?
CBC - Hypereosinophilia
Serum immunoglobulin - increased IgE level
ETO radioallergosorbent test (RAST) IgE antibody (dialyzer first use reaction)
Formaldehyde test (dialyzer reuse reaction)
How should patients with anaphylactic/anaphylactoid reactions be managed?
Acute management
Stop dialysis
Do not re-infuse extracorporeal blood
Epinephrine
Corticosteroids
Antihistamines
Intubation for acute respiratory failure/arrest
Prevention
Adequate rinsing techniques for both new and reused dialyzers
Use of steam-sterilized, gamma-irradiated- or electron-beam-sterilized dialyzer
Avoidance of AN69 dialyzer or Renalin reused dialyzer in patients receiving ACE inhibitor
Test-dose iron dextran (resuscitative medications should be available)
Use iron sucrose as an alternative to iron dextran
What happens to patients with anaphylactic/anaphylactoid reactions?
Risk of death if unrecognized or treatment delayed
How to utilize team care?
1. Specialty consultations - Call 911 (free-standing dialysis facility) or code team (hospital-based dialysis facility) if sudden cardiac arrest.
2. Nurses - Monitoring of patients with history of atopy, eosinophilia and those prescribed ACE inhibitors.
Are there clinical practice guidelines to inform decision making?
Applications
2006 Clinical practice guidelines for anemia in chronic kidney disease (Published by National Kidney Foundation, K/DOQI)
2008 Emergency treatment of anaphylactic reactions-guidelines for healthcare providers (Published by Resuscitation Council UK)
Limitations - paucity of data on management of anaphylaxis in dialysis patients
Other considerations
ICD-10-CM diagnosis code T78.2: Anaphylactic shock, unspecified
What is the evidence?
"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease". Am J Kidney Dis. vol. 47. 2006. pp. S11-145.
Soar, J, Pumphrey, R, Cant, A, Clarke, S, Corbett, A, Dawson, P, Ewan, P, Foëx, B, Gabbott, D, Griffiths, M, Hall, J, Harper, N, Jewkes, F, Maconochie, I, Mitchell, S, Nasser, S, Nolan, J, Rylance, G, Sheikh, A, Unsworth, DJ, Warrell, D. "Working Group of the Resuscitation Council (UK). Emergency treatment of anaphylactic reactions--guidelines for healthcare providers". Resuscitation. vol. 77. 2008. pp. 157-69.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Identifying the Needs of Multidisciplinary Team Treating Geriatics Cancer Patients
- Sequence of Immunotherapy, Targeted Therapy, Radiation Therapy Influences Overall Survival in Melanoma Brain Metastases
- Survey Demonstrates Implicit Bias Toward Cervical Cancer Diagnoses Among Nurses, Women
- Use of Watchful Waiting Up for Low-Risk Localized Prostate Cancer
- Sharing Personal Contact Information With Patients
- Country-Specific Norms Created for Cancer-Related Quality of Life
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |